Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for IRONWOOD PHARMACEUTICALS INC Class A Stock (IRWD).
- Disclosed ownership: 7.1%.
- Date of event: 28 Feb 2025.
BlackRock, Inc. - 28 Feb 2025 SCHEDULE 13G/A Report for IRONWOOD PHARMACEUTICALS INC Class A Stock (IRWD)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- IRWD
- Shares outstanding
- 158,935,197 shares
- Disclosed Ownership
- 11,284,399 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Mar 2025, 12:19:46 UTC
- Date of event
- 28 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 7.1% ownership in IRONWOOD PHARMACEUTICALS INC Class A Stock (IRWD) on 28 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Mar 2025, 12:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 7.1% | 11,284,399 | 11,058,821 | Spencer Fleming | Managing Director |